Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Sonnet BioTherapeutics Holdings, Inc. (SONN) had Earnings per Share (EPS) (Basic) of $-0.95 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.78M |
|
-- |
|
-- |
|
$3.81M |
|
$-3.81M |
|
$0.03M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.81M |
|
$-3.78M |
|
3.96M |
|
3.96M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.95 |
$-0.95 |
|
| Balance Sheet Financials | |
$1.32M |
|
$0.01M |
|
$0.74M |
|
$2.06M |
|
$5.10M |
|
-- |
|
-- |
|
$5.10M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
3.33M |
|
| Cash Flow Statement Financials | |
$-7.14M |
|
$-0.01M |
|
$7.32M |
|
$0.15M |
|
$0.32M |
|
$0.17M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
123.94% |
|
123.94% |
|
-183.71% |
|
123.94% |
|
$-0.91 |
|
$-1.80 |
|
$-1.80 |
|